• Jump to main navigation
  • Jump to content
U of U Health
  • Billing & Insurance
  • MyChart
Search
  • Find A U of U Health Doctor
  • All U of U Health Services
  • All U of U Health Locations
  • For All U of U Health Patients & Visitors
    • Patient Services
      • Questions About Your Bill?
      • Urgent Care
      • Where to Stay
      • Patients & Family Services
      • Clinical Trials
    • University of Utah Hospital
      • University of Utah Hospital
      • Staying at the Hospital
      • Parking & Valet
      • Looking for Another Location?
    • General Questions
      • 801-581-2668
      • Find an Interpreter
      • About U of U Health
  • Billing & Insurance
  • MyChart
  • Search

Wade S. Samowitz, MD

  • Clinical Information
  • Academic Information
  • Clinical Trials
  • Patient Resources
  • Videos & News
No Rating Available?
In order to provide our patients and visitors with the most accurate and useful information, we only post physician satisfaction data when a physician has received a minimum of 30 returned surveys. For this provider, we have not yet received the minimum.
0 out of 5 Patient Rating

Languages Spoken: English, Italian

Dr. Samowitz is the medical director for numerous molecular tests in gastrointestinal cancer and other tumors, including microsatellite instability by IHC and PCR, mutational testing for BRAF, PIK3CA, and NRAS, evaluation for molar pregnancy, and specimen identification.

Specialties

  • Pathology
  • Surgical Pathology
  • Gastrointestinal Pathology

Board Certification and Academic Information

Academic Departments Pathology - Professor
Academic Divisions Anatomic Pathology
Board Certification American Board of Pathology (Sub: Anatomic Path)

Dr. Samowitz is the medical director for numerous molecular tests in gastrointestinal cancer and other tumors, including microsatellite instability by IHC and PCR, mutational testing for BRAF, PIK3CA, and NRAS, evaluation for molar pregnancy, and specimen identification.

Academic Locations

Board Certification and Academic Information

Academic Departments Pathology - Professor
Academic Divisions Anatomic Pathology
Board Certification American Board of Pathology (Sub: Anatomic Path)

Research Interests

  • Colorectal Cancer Genetics

Education History

Fellowship Johns Hopkins University
Pathology
Fellow, 1987
Residency University of Chicago Hospital
Pathology
Resident, 1985
Fellowship University of Texas Health Science Center
Cardiovascular Pathology
Fellow, 1982
Internship University of Texas Southwestern Medical School
Internal Medicine
Intern, 1982
Professional Medical SUNY at Brooklyn
Medicine
M.D., 1981
Undergraduate Cornell University College of Arts and Sciences

B.A., 1977

Selected Publications - Journal Articles

Journal Article

  1. Samadder NJ, Neklason D, Snow A, Samowitz W, Cessna MH, Rowe K, Sandhu I, Boucher K, Pappas L, Smith KR, Wong J, Curtin K, Provenzale D, Burt RW (2019). Clinical and Molecular Features of Post-Colonoscopy Colorectal Cancers. Clin Gastroenterol Hepatol, 17(13), 2731-2739.e2.
  2. Sample DC, Samadder NJ, Pappas LM, Boucher KM, Samowitz WS, Berry T, Westover M, Nathan D, Kanth P, Byrne KR, Burt RW, Neklason DW (2018). Variables affecting penetrance of gastric and duodenal phenotype in familial adenomatous polyposis patients. BMC Gastroenterol, 18(1), 115.
  3. Pellatt AJ, Mullany LE, Herrick JS, Sakoda LC, Wolff RK, Samowitz WS, Slattery ML (2018). The TGFβ-signaling pathway and colorectal cancer: associations between dysregulated genes and miRNAs. J Transl Med, 16(1), 191.
  4. Wolff RK, Hoffman MD, Wolff EC, Herrick JS, Sakoda LC, Samowitz WS, Slattery ML (2018). Mutation analysis of adenomas and carcinomas of the colon: Early and late drivers. Genes Chromosomes Cancer, 57(7), 366-376.
  5. Slattery ML, Mullany LE, Wolff RK, Sakoda LC, Samowitz WS, Herrick JS (2018). The p53-signaling pathway and colorectal cancer: Interactions between downstream p53 target genes and miRNAs. Genomics.
  6. Samadder NJ, Kuwada SK, Boucher KM, Byrne K, Kanth P, Samowitz W, Jones D, Tavtigian SV, Westover M, Berry T, Jasperson K, Pappas L, Smith L, Sample D, Burt RW, Neklason DW (2018). Association of Sulindac and Erlotinib vs Placebo With Colorectal Neoplasia in Familial Adenomatous Polyposis: Secondary Analysis of a Randomized Clinical Trial. JAMA Oncol, 4(5), 671-677.
  7. Mullany LE, Herrick JS, Sakoda LC, Samowitz W, Stevens JR, Wolff RK, Slattery ML (2019). MicroRNA-messenger RNA interactions involving JAK-STAT signaling genes in colorectal cancer. Genes Cancer, 9(5-6), 232-246.
  8. Mullany LE, Herrick JS, Wolff RK, Stevens JR, Samowitz W, Slattery ML (2017). MicroRNA-transcription factor interactions and their combined effect on target gene expression in colon cancer cases. Genes Chromosomes Cancer, 57(4), 192-202.
  9. Slattery ML, Mullany LE, Sakoda LC, Wolff RK, Samowitz WS, Herrick JS (2018). Dysregulated genes and miRNAs in the apoptosis pathway in colorectal cancer patients. Apoptosis, 23(3-4), 237-250.
  10. Dehghanizadeh S, Khoddami V, Mosbruger TL, Hammoud SS, Edes K, Berry TS, Done M, Samowitz WS, DiSario JA, Luba DG, Burt RW, Jones DA (2018). Active BRAF-V600E is the key player in generation of a sessile serrated polyp-specific DNA methylation profile. PLoS One, 13(3), e0192499.
  11. Slattery ML, Mullany LE, Sakoda LC, Wolff RK, Samowitz WS, Herrick JS (2018). The MAPK-Signaling Pathway in Colorectal Cancer: Dysregulated Genes and Their Association With MicroRNAs. Cancer Inform, 17, 1176935118766522.
  12. Slattery ML, Mullany LE, Sakoda L, Samowitz WS, Wolff RK, Stevens JR, Herrick JS (2017). The NF-κB signalling pathway in colorectal cancer: associations between dysregulated gene and miRNA expression. J Cancer Res Clin Oncol, 144(2), 269-283.
  13. Mullany LE, Herrick JS, Sakoda LC, Samowitz W, Stevens JR, Wolff RK, Slattery ML (2018). miRNA involvement in cell cycle regulation in colorectal cancer cases. Genes Cancer, 9(1-2), 53-65.
  14. Slattery ML, Mullany LE, Sakoda LC, Samowitz WS, Wolff RK, Stevens JR, Herrick JS (2017). Expression of Wnt-signaling pathway genes and their associations with miRNAs in colorectal cancer. Oncotarget, 9(5), 6075-6085.

News Articles

Colon Cancer: Know Your Risk

Site Links

  • Find an Interpreter
  • About Us
  • Academics & Research
  • Billing
  • Jobs
  • Giving
  • Maps & Directions
  • Newsroom
  • Referring Providers

Helpful Links

  • Patient Rights & Responsibilities
  • Disclaimer
  • Privacy Statement
  • DNV GL Public Information Policy Statement
  • Non-Discrimination Policy
  • Surprise Billing Rights
  • Webmaster

Contact Us

University of Utah Health

50 North Medical Drive
Salt Lake City, UT 84132

801-581-2121

  • Facebook
  • Twitter
  • Youtube
  • Instagram

University of Utah

All clinical services and programs are part of University of Utah Health Hospitals and Clinics.

Copyright © 2022 University of Utah Health